KETANKUMAR GHAGHADA to Cell Line, Tumor
This is a "connection" page, showing publications KETANKUMAR GHAGHADA has written about Cell Line, Tumor.
Connection Strength
0.262
-
Heterogeneous Uptake of Nanoparticles in Mouse Models of Pediatric High-Risk Neuroblastoma. PLoS One. 2016; 11(11):e0165877.
Score: 0.083
-
Folate targeting of drug carriers: a mathematical model. J Control Release. 2005 May 05; 104(1):113-28.
Score: 0.037
-
HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells. Biol Open. 2022 09 15; 11(9).
Score: 0.031
-
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma. Nat Commun. 2022 06 28; 13(1):3728.
Score: 0.030
-
MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma. Sci Rep. 2021 02 03; 11(1):2967.
Score: 0.028
-
Delivery of drugs into brain tumors using multicomponent silica nanoparticles. Nanoscale. 2019 Jun 20; 11(24):11910-11921.
Score: 0.025
-
Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. J Control Release. 2014 Jan 10; 173:51-8.
Score: 0.017
-
Micro-CT imaging of breast tumors in rodents using a liposomal, nanoparticle contrast agent. Int J Nanomedicine. 2009; 4:277-82.
Score: 0.012